Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NET”

453 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 453 results

Not applicableUnknownNCT03958188
What this trial is testing

PreOPerative Imaging of NeuroEndocrine Tumors

Who this might be right for
Neuro-endocrine TumorsSmall Intestine Cancer
Hospices Civils de Lyon 47
Not applicableUnknownNCT03812939
What this trial is testing

Recurrence Rates of Type I Gastric Neuroendocrine Tumors Treated With Long-acting Somatostatin Analogs

Who this might be right for
Gastric NET
Peking Union Medical College Hospital 30
Not applicableEnded earlyNCT03553732
What this trial is testing

An Electronic Registry to Improve Adherence to Active Surveillance Monitoring at a Safety-net Hospital

Who this might be right for
Prostatic Neoplasms
University of California, San Francisco 48
Not applicableUnknownNCT01112592
What this trial is testing

NETs Formation in Patients With Recurrent Pyogenic Infections (NETS)

Who this might be right for
Pyogenic Infections
Meir Medical Center 100
Not applicableStudy completedNCT04297228
What this trial is testing

Pediatric Obesity Treatment in a Safety Net Clinic: Piloting the Step by Step Program

Who this might be right for
Pediatric ObesityOverweight and Obesity
Community Volunteers In Medicine 16
Testing effectiveness (Phase 2)Study completedNCT02955069
What this trial is testing

Study of Efficacy and Safety of PDR001 in Patients With Advanced or Metastatic, Well-differentiated, Non-functional Neuroendocrine Tumors of Pancreatic, Gastrointestinal (GI), or Thoracic Origin or Poorly-differentiated Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC)

Who this might be right for
Well-differentiated Non-functional NET of Thoracic OriginWell-differentiated Non-functional NET of Gastrointestinal OriginWell-differentiated Non-functional NET of Pancreatic Origin+1 more
Novartis Pharmaceuticals
Not applicableStudy completedNCT04177576
What this trial is testing

Evaluation of New Biomarkers of Thrombosis in Myeloproliferative Neoplasms

Who this might be right for
Myeloproliferative Neoplasm
University Hospital, Bordeaux 397
Not applicableStudy completedNCT02922855
What this trial is testing

Incentives for Primary Care Use in a Safety Net Setting

Who this might be right for
Health Care UtilizationPrimary Care PhysicianUninsured
Virginia Commonwealth University 1,228
Large-scale testing (Phase 3)Study completedNCT00510068
What this trial is testing

Efficacy and Safety of Everolimus (RAD001) Compared to Placebo in Patients With Advanced Neuroendocrine Tumors

Who this might be right for
Advanced Neuroendocrine Tumors of Pancreatic Origin
Novartis Pharmaceuticals 410
Large-scale testing (Phase 3)Looking for participantsNCT03368092
What this trial is testing

Inhaled Dornase Alpha to Reduce Respiratory Failure After Severe Trauma

Who this might be right for
Multiple TraumaRespiratory Distress Syndrome, Adult
University Hospital, Strasbourg, France 500
Early research (Phase 1)Ended earlyNCT04258592
What this trial is testing

18F-MFBG PET Imaging of the Norepinephrine Transporter in Neural Crest and Neuroendocrine Tumors

Who this might be right for
Neural Crest TumorNeuroendocrine Tumors
Universitaire Ziekenhuizen KU Leuven 6
Not applicableUnknownNCT03982264
What this trial is testing

Endoscopic Treatment of Rectal Neuroendocrine Tumor(NET) Less Than 10mm

Who this might be right for
Rectal Neuroendocrine Tumor
Nanfang Hospital, Southern Medical University 90
Not applicableStudy completedNCT04545905
What this trial is testing

Antenatal Care as a Platform for Malaria Surveillance: Utilizing Community Prevalence Measures From the New Nets Project to Validate ANC Surveillance of Malaria in Burkina Faso

Who this might be right for
Malaria
PATH 13,350
Not applicableStudy completedNCT03791346
What this trial is testing

Pancreatectomy for NET: External Evaluation of WHO 2017 Grading System

Who this might be right for
Pancreatic Surgery
University Hospital, Montpellier 138
Testing effectiveness (Phase 2)WithdrawnNCT06233903
What this trial is testing

18F-mFBG Expression in Neural Crest Tumors and Organs Innervated by the Sympathetic Nervous System

Who this might be right for
NeuroblastomaPheochromocytomaParaganglioma
Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)
Not applicableUnknownNCT05106673
What this trial is testing

Clinical Implementation and Evaluation for the Family-oriented Care CHIMPS-NET

Who this might be right for
Mental Health Issue
Universitätsklinikum Hamburg-Eppendorf 798
Not applicableLooking for participantsNCT07319416
What this trial is testing

DCEUS to Assess Treatment Response to PRRT in GEP-NET

Who this might be right for
NETRadionucleide TherapyContrast Enhanced Ultrasound
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 30
Not applicableUnknownNCT04412382
What this trial is testing

Covid-19: Possible Role of Neutrophil Extracellular Traps

Who this might be right for
Covid-19
Azienda Ospedaliera Universitaria Integrata Verona 100
Testing effectiveness (Phase 2)WithdrawnNCT04276597
What this trial is testing

Phase-II Study of Lu177DOTATOC in Adults With STTR(+)Pulmonary, Pheochromocytoma, Paraganglioma, Unknown Primary, Thymus NETs (PUTNET), or Any Other Non-.GEP-NET.

Who this might be right for
Pulmonary Neuroendocrine NeoplasmPheochromocytomaParaganglioma+7 more
Excel Diagnostics and Nuclear Oncology Center
Testing effectiveness (Phase 2)Study completedNCT04296149
What this trial is testing

Beta- Probe and Surgery in GEP NET: Evaluation of a New Probe

Who this might be right for
Neuroendocrine Tumors
European Institute of Oncology 5
Next Page
116